Hypoglycemia is common and dangerous in diabetes mellitus, so identifying at-risk patients may lead to useful preventive strategies. This Regenstrief-Merck partnership aims to design a risk calculator to aid clinicians in identifying at-risk patients who may benefit from preventive strategies. The project team members will conduct a retrospective cohort analysis, focus-group discussions, use of a new computer-based risk-prediction tool, and assessment of processes and outcomes associated with usage of the tool among healthcare providers.
-
Research
- Experts
In The News
View AllMSN features Dr. Brian Dixon
Brian Dixon, PhD, MPA, was interviewed by WISH TV on...
Influence
View AllRegenstrief researcher on author list for 1 of JAMA’s 2024 most viewed papers
A paper co-authored by Regenstrief Research Scientist Sarah Wiehe, M.D.,...
- Opportunities
Featured Fellowship
View all- About
Regenstrief envisions a world where better information empowers people to end disease and realize true health.
- The Latest
- Experts